Loading…
Arvaya Healthcare (BSE 524723)₹110.00−0.90%Trading & Distributors
In the Jun 2026 quarter (consolidated), Arvaya Healthcare reported sales of ₹29.80 Cr and net profit of ₹0.54 Cr. For the year to Mar 2026, sales were ₹9.08 Cr and net profit ₹0.91 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Jun 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|
| Sales | 0.00 | 9.08 | 29.80 |
| Expenses | 0.29 | 7.74 | 25.96 |
| Operating Profit | −0.29 | 1.39 | 3.97 |
| OPM % | — | 15.2% | 13.3% |
| Other Income | 0.04 | 1.31 | 0.20 |
| Interest | 0.00 | 0.42 | 1.40 |
| Depreciation | 0.00 | 0.63 | 2.21 |
| Profit before tax | −0.24 | 1.64 | 0.55 |
| Tax % | 0.0% | 11.5% | 5.4% |
| Net Profit | −0.24 | 1.48 | 0.54 |
| EPS (Rs) | −0.34 | 0.27 | 0.09 |
| Mar 2026 | |
|---|---|
| Sales | 9.08 |
| Expenses | 8.40 |
| Operating Profit | 0.73 |
| OPM % | 7.9% |
| Other Income | 1.41 |
| Interest | 0.42 |
| Depreciation | 0.63 |
| Profit before tax | 1.08 |
| Tax % | 17.4% |
| Net Profit | 0.91 |
| EPS (Rs) | 0.16 |
| Dividend payout % | 0.0% |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Cash from operating activity | — | −3.29 |
| Cash from investing activity | — | −7.01 |
| Cash from financing activity | — | 8.51 |
| Net cash flow | — | −1.80 |
| Capex | 0.00 | 4.67 |
| Free cash flow | — | −7.95 |
| CFO / OP % | — | −456.0% |
For the Jun 2026 quarter, Arvaya Healthcare reported sales of ₹29.80 Cr and net profit of ₹0.54 Cr. The operating margin was 13.3%.
Arvaya Healthcare's sales for the year to Mar 2026 were ₹9.08 Cr.
Net profit for the year to Mar 2026 was ₹0.91 Cr. Earnings per share over the same trailing period were ₹0.16.
Cash from operations was −₹3.29 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹7.95 Cr.